Periodontal tissue regeneration by recombinant human collagen peptide granules applied with β-tricalcium phosphate fine particles
Copyright © 2023 Japanese Association for Oral Biology. Published by Elsevier B.V. All rights reserved..
OBJECTIVES: Recombinant human collagen peptide (RCP) is a recombinantly created xeno-free biomaterial enriched in arginine-glycine-aspartic acid sequences with good processability whose use for regenerative medicine applications is under investigation. The biocompatibility and osteogenic ability of RCP granules combined with β-tricalcium phosphate (TCP) submicron particles (β-TCP/RCP) were recently demonstrated. In the present study, β-TCP/RCP was implanted into experimental periodontal tissue defects created in beagles to investigate its regenerative effects.
METHODS: An RCP solution was lyophilized, granulated, and thermally cross-linked into particles approximately 1 mm in diameter. β-TCP dispersion (1 wt%; 500 μL) was added to 100 mg of RCP granules to form β-TCP/RCP. A three-walled intrabony defect (5 mm × 3 mm × 4 mm) was created on the mesial side of the mandibular first molar and filled with β-TCP/RCP.
RESULTS: A micro-computed tomography image analysis performed at 8 weeks postoperative showed a significantly greater amount of new bone after β-TCP/RCP grafting (2.2-fold, P < 0.05) than after no grafting. Histological findings showed that the transplanted β-TCP/RCP induced active bone-like tissue formation including tartaric acid-resistant acid phosphatase- and OCN-positive cells as well as bioabsorbability. Ankylosis did not occur, and periostin-positive periodontal ligament-like tissue formation was observed. Histological measurements performed at 8 weeks postoperative revealed that β-TCP/RCP implantation formed 1.7-fold more bone-like tissue and 2.1-fold more periodontal ligament-like tissue than the control condition and significantly suppressed gingival recession and epithelial downgrowth (P < 0.05).
CONCLUSIONS: β-TCP/RCP implantation promoted bone-like and periodontal ligament-like tissue formation, suggesting its efficacy as a periodontal tissue regenerative material.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:65 |
---|---|
Enthalten in: |
Journal of oral biosciences - 65(2023), 1 vom: 12. März, Seite 62-71 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Yoshino, Yuto [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 07.03.2023 Date Revised 09.03.2023 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.job.2023.01.002 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM351804242 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM351804242 | ||
003 | DE-627 | ||
005 | 20231226052242.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.job.2023.01.002 |2 doi | |
028 | 5 | 2 | |a pubmed24n1172.xml |
035 | |a (DE-627)NLM351804242 | ||
035 | |a (NLM)36669699 | ||
035 | |a (PII)S1349-0079(23)00002-6 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Yoshino, Yuto |e verfasserin |4 aut | |
245 | 1 | 0 | |a Periodontal tissue regeneration by recombinant human collagen peptide granules applied with β-tricalcium phosphate fine particles |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 07.03.2023 | ||
500 | |a Date Revised 09.03.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2023 Japanese Association for Oral Biology. Published by Elsevier B.V. All rights reserved. | ||
520 | |a OBJECTIVES: Recombinant human collagen peptide (RCP) is a recombinantly created xeno-free biomaterial enriched in arginine-glycine-aspartic acid sequences with good processability whose use for regenerative medicine applications is under investigation. The biocompatibility and osteogenic ability of RCP granules combined with β-tricalcium phosphate (TCP) submicron particles (β-TCP/RCP) were recently demonstrated. In the present study, β-TCP/RCP was implanted into experimental periodontal tissue defects created in beagles to investigate its regenerative effects | ||
520 | |a METHODS: An RCP solution was lyophilized, granulated, and thermally cross-linked into particles approximately 1 mm in diameter. β-TCP dispersion (1 wt%; 500 μL) was added to 100 mg of RCP granules to form β-TCP/RCP. A three-walled intrabony defect (5 mm × 3 mm × 4 mm) was created on the mesial side of the mandibular first molar and filled with β-TCP/RCP | ||
520 | |a RESULTS: A micro-computed tomography image analysis performed at 8 weeks postoperative showed a significantly greater amount of new bone after β-TCP/RCP grafting (2.2-fold, P < 0.05) than after no grafting. Histological findings showed that the transplanted β-TCP/RCP induced active bone-like tissue formation including tartaric acid-resistant acid phosphatase- and OCN-positive cells as well as bioabsorbability. Ankylosis did not occur, and periostin-positive periodontal ligament-like tissue formation was observed. Histological measurements performed at 8 weeks postoperative revealed that β-TCP/RCP implantation formed 1.7-fold more bone-like tissue and 2.1-fold more periodontal ligament-like tissue than the control condition and significantly suppressed gingival recession and epithelial downgrowth (P < 0.05) | ||
520 | |a CONCLUSIONS: β-TCP/RCP implantation promoted bone-like and periodontal ligament-like tissue formation, suggesting its efficacy as a periodontal tissue regenerative material | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a Animals | |
650 | 4 | |a Biocompatible materials | |
650 | 4 | |a Bone formation | |
650 | 4 | |a Immunohistochemistry | |
650 | 4 | |a Periodontal ligament | |
650 | 7 | |a beta-tricalcium phosphate |2 NLM | |
650 | 7 | |a Collagen |2 NLM | |
650 | 7 | |a 9007-34-5 |2 NLM | |
650 | 7 | |a Recombinant Proteins |2 NLM | |
650 | 7 | |a Peptides |2 NLM | |
700 | 1 | |a Miyaji, Hirofumi |e verfasserin |4 aut | |
700 | 1 | |a Nishida, Erika |e verfasserin |4 aut | |
700 | 1 | |a Kanemoto, Yukimi |e verfasserin |4 aut | |
700 | 1 | |a Hamamoto, Asako |e verfasserin |4 aut | |
700 | 1 | |a Kato, Akihito |e verfasserin |4 aut | |
700 | 1 | |a Sugaya, Tsutomu |e verfasserin |4 aut | |
700 | 1 | |a Akasaka, Tsukasa |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of oral biosciences |d 2008 |g 65(2023), 1 vom: 12. März, Seite 62-71 |w (DE-627)NLM194012034 |x 1880-3865 |7 nnns |
773 | 1 | 8 | |g volume:65 |g year:2023 |g number:1 |g day:12 |g month:03 |g pages:62-71 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.job.2023.01.002 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 65 |j 2023 |e 1 |b 12 |c 03 |h 62-71 |